Skip to main content

Original Research
Characterization of A Dose-Dense Doxorubicin and Cyclophosphamide Regimen for Triple-Negative Breast Cancer Within the KEYNOTE-522 Trial
Samantha Hodges, PharmD; Katelyn Patterson, PharmD; Vera Ljucovic, PharmD
Read Article
Original Research
Characterizing Lenalidomide Dose Modifications Among Black and Non-Black Patients Receiving Induction Therapy for Newly Diagnosed Multiple Myeloma
Laura Fan Sun, PharmD, BCOP; Natalie Brumwell, PharmD; Kevin Hall, PharmD; Kristina Murphy, PharmD; Jeffrey Switchenko, PhD; Yichun Cao, MPH, et al.
Read Article
Original Research
Outcomes of Early Versus Delayed Initiation of Immunotherapy in Patients With Extensive-Stage Small Cell Lung Cancer
Matthew Warrick, PharmD, BCPS, BCOP; Rebecca Worden, PharmD, BCOP; Carly Kesler, PharmD, BCOP; Katie Murto, PharmD, BCOP; Amanda Edwards, PharmD, BCOP, CPP
Read Article
Original Research
Impact of Hyperglycemia During Immune Checkpoint Inhibitor Treatment for Advanced Non–Small Cell Lung Cancer: A Retrospective, Single-Center Study
Allison L. Thurman, PharmD; Susan Storey, PhD, RN, ACONS, FCNS; David J. Reeves, PharmD, BCOP
Read Article
 
 

JHOP - March 2026 Vol 16 Special Feature

Download HOPA Abstracts  Read More
Editorial
Hope Springs Eternal: A New Year of HOPA Annual Conference Research Abstracts
Courtney C. Cavalieri, PharmD, BCOP; Michael Williams, PharmD, BCOP
READ ARTICLE
HOPA Abstracts
Evaluation of a Biosimilar Conversion in an Academic Medical Center Outpatient Infusion Center
Sidney Keisner, PharmD, BCOP
READ ARTICLE
HOPA Abstracts
Outcomes of Supportive Care Versus Pharmacologic Intervention for the Management of CRS in Relapsed or Refractory Multiple Myeloma Treated With BCMA- and GPRC5D-Directed Bispecifics
Victoria Nachar, PharmD, BCOP; James Davis, PharmD, BCOP
READ ARTICLE
HOPA Abstracts
From Diagnosis to Decision-Making: Black Patient and Caregiver Perspectives on Lung Cancer Care and Support Needs
Shanada Monestime, PharmD, BCOP
READ ARTICLE
HOPA Abstracts
Safety of Live-Attenuated MMR Vaccination in Patients With Multiple Myeloma Receiving Daratumumab After Autologous Stem-Cell Transplantation
James A. Davis, PharmD, BCOP
READ ARTICLE
HOPA Abstracts
A Real-World Analysis of Filgrastim and Biosimilars for Engraftment After Hemopoietic Cell Transplantation: Balancing Efficacy and Economics
Dennis Marjoncu, PharmD, BCOP; Kori Holman, PharmD, BCOP
READ ARTICLE